In breast cancer, PDOs have been shown to preserve the histological and molecular characteristics of the original tumors, including key markers such as estrogen receptor (ER), progesterone receptor (PR), and HER2, copy number variations, and sequence alterations [29]. Here, ERBB2 is linked to breast carcinoma.